Chemotherapy for metastatic bladder cancer; the EORTC experience.
Stoter
G
G
Department of Oncology, Rotterdam Cancer Institute, The Netherlands.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005060:Europe; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D002945:Cisplatin; D008727:Methotrexate